Stephen A. Trowbridge - Jul 15, 2022 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
EVP and CFO
Signature
/s/ Richard C. Rosenzweig, Attorney in Fact
Stock symbol
ANGO
Transactions as of
Jul 15, 2022
Transactions value $
-$28,935
Form type
4
Date filed
7/18/2022, 04:13 PM
Previous filing
Jul 11, 2022
Next filing
Jul 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Options Exercise $235K +14.8K +18.88% $15.95 92.9K Jul 15, 2022 Direct
transaction ANGO Common Stock Tax liability -$264K -12.4K -13.34% $21.32 80.5K Jul 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANGO Non- Qualified Stock Option (right to buy) Options Exercise $0 -14.8K -100% $0.00* 0 Jul 15, 2022 Common Stock 14.8K $15.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exempt disposition of 12,398 shares of common stock of AngioDynamics, Inc. (the "Company") to the Company was made to satisfy the exercise price arising from a net (cashless) exercise of stock options that were set to expire on 7/22/2022.
F2 Options for one-fourth of the shares were each exercisable beginning 7/22/2016, 7/22/2017, 7/22/2018 and 7/22/2019, respectively.